Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIOSTIM AS
AS
Active
Org 934620445
Brevikveien 68, 1555 Son
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 1983
0 employees
www.biostim.no
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2022
NOK 475K
+4% vs 2021
EBITDA margin
8.2%
+782% vs 2021
Equity ratio
65.7%
Financial strength
Net profit 2022
NOK 34K
+813% vs 2021
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
0M
0%
2022
Key figures
Annual report 2022
Revenue
NOK 475K
+4%
EBITDA
NOK 39K
+782%
Net profit
NOK 34K
+813%
Total assets
NOK 180K
+2%
Equity
NOK 118K
+40%
Employees
0
—
Company information
Legal name
BIOSTIM AS
Org number
934620445
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. desember 1983
Share capital
NOK 102 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Contact
Address
Brevikveien 68, 1555 Son
Website
www.biostim.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Vestby
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2018
1M
2019
0M
2020
0M
2021
0M
2022
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
0M
2022
Income statement
NOK thousands
Item
2018
2019
2020
2021
2022
Revenue
593
510
444
459
475
Staff expenses
−205
−120
−110
−142
−110
EBITDA
−11
14
12
−6
39
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−11
14
12
−6
39
Net financials
−5
−4
−3
0
−5
Profit before tax
−16
10
9
−6
34
Tax
−1
2
2
−1
−0
Net profit
−15
8
7
−5
34
Balance sheet
NOK thousands
Item
2018
2019
2020
2021
2022
Total assets
181
182
208
176
180
Equity
74
82
89
84
118
Long-term debt
0
25
0
0
0
Short-term debt
107
75
119
92
62
Total debt
107
100
119
92
62
Financial ratios
5-year trend
EBITDA margin
8.2%
This company
15.8%
Market median
-48% vs market
2018
2022
Equity ratio
65.7%
This company
38.2%
Market median
+72% vs market
2018
2022
Return on equity
28.8%
This company
18.4%
Market median
+57% vs market
2018
2022
Net profit margin
7.1%
This company
8.1%
Market median
-12% vs market
2018
2022
Asset turnover
2.64×
This company
1.12×
Market median
+136% vs market
2018
2022
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
KØ
Kjell Øivind Hansen
Chairman
2014
AM
Anne Martha Hansen
Deputy Chairman
2014
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BIOSTIM AS also hold positions in
0
other companies.
Person
Role here
Other companies
Kjell Øivind Hansen
Chairman
0 companies
Anne Martha Hansen
Deputy Chairman
0 companies